Summary
Definition
History and exam
Key diagnostic factors
- exposure to fungal spores
- risk factors that impair host defenses
- fever
- headache
- dyspnea
- dry or nonproductive cough
- pleuritic chest pain
- anorexia
- productive cough
Other diagnostic factors
- abdominal pain
- fatigue
- malaise
- arthralgias
- weight loss
- hepatosplenomegaly
- scattered crackles on chest auscultation
- bronchial breathing on chest auscultation
- distant breath sounds on chest auscultation
- hemoptysis
- meningitis-like symptoms
- skin lesions
- gastrointestinal symptoms
- sepsis-like syndrome
Risk factors
- exposure to fungus
- emphysema
- HIV infection
- treatment with tumor necrosis factor (TNF)-alpha antagonists
- treatment with corticosteroids
- treatment with other immunosuppressants and biologic agents
- primary immunodeficiency (especially those associated with T-cell impairment)
- stem cell and solid organ transplant
- graft-versus-host disease
Diagnostic investigations
1st investigations to order
- chest x-ray
- culture
- antigen testing
- serology (immunodiffusion precipitin test)
- serology (complement fixation assay)
- serology (enzyme immunoassay)
- CT scan of chest
- CBC
- LFTs
Investigations to consider
- tissue biopsy
Treatment algorithm
asymptomatic pulmonary disease (nonpregnant)
symptomatic pulmonary disease (nonpregnant)
chronic pulmonary disease (nonpregnant)
disseminated disease (nonpregnant)
mediastinal granuloma (nonpregnant)
mediastinal fibrosis (nonpregnant)
broncholithiasis (nonpregnant)
pericarditis (nonpregnant)
rheumatologic syndrome (nonpregnant)
meningoencephalitis (nonpregnant)
pregnant
Contributors
Authors
David L. Goldman, MD
Associate Professor
Pediatric Infectious Diseases
The Children's Hospital at Montefiore
Bronx
NY
Disclosures
DLG declares that he has no competing interests.
Philip Lee, Pharm D
Clinical Pharmacist for Pediatric Infectious Disease
The Children’s Hospital at Montefiore
Bronx
New York
Disclosures
PL declares that he has no competing interests.
Acknowledgements
Dr David L. Goldman and Dr Philip Lee would like to gratefully acknowledge Dr Zainab A. Malik, a previous contributor to this topic.
Peer reviewers
Kassem Hammoud, MD
Associate Professor
Division of Infectious Diseases
University of Kansas Health System
Kansas City
MI
Disclosures
KH declares that he has no competing interests.
Adriana M. Rauseo, MD
Assistant Professor of Medicine
Division of Infectious Diseases
Department of Internal Medicine
Washington University in St Louis
St Louis
MI
Disclosures
AMR declares that she has no competing interests.
Paul Roberts, MD
Assistant Professor
Family Medicine
Mayo Clinic
Jacksonville
FL
Disclosures
PR declares that he has no competing interests.
Janak Koirala, MD
Associate Professor of Medicine
Division of Infectious Diseases
Department of Internal Medicine
Southern Illinois University School of Medicine
Springfield
IL
Disclosures
JK declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Infectious Diseases Society of America. IDSA 2025 guideline update on the treatment of asymptomatic histoplasma pulmonary nodules (histoplasmomas) and mild or moderate acute pulmonary histoplasmosis in adults, children, and pregnant people. Mar 2025 [internet publication].Full text
Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec;21(12):e364-74.Full text Abstract
National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and the Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: histoplasmosis. Oct 2024 [internet publication].Full text
Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep 1;200(5):535-50.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Differentials
- Community-acquired pneumonia
- Pneumocystis jirovecii pneumonia (PCP)
- Pulmonary tuberculosis
More DifferentialsGuidelines
- IDSA 2025 guideline update on the treatment of asymptomatic histoplasma pulmonary nodules (histoplasmomas) and mild or moderate acute pulmonary histoplasmosis in adults, children, and pregnant people
- Testing algorithms for fungal pneumonias
More GuidelinesLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer